Chimalakonda, A., Burke, J., Cheng, L., Catlett, I., Patel, A., Shen, J., Girgis, I., Banerjee, S., & Throup, J. (2020). Selective Inhibition of Tyrosine Kinase 2 With Deucravacitinib (BMS-986165) Compared With Janus Kinase 1−3 Inhibitors. SKIN The Journal of Cutaneous Medicine, 4(6), s108. https://doi.org/10.25251/skin.4.supp.108